Graça Sequeira
YOU?
Author Swipe
View article: Sociodemographic factors and biologic therapy exposure impacting health-related quality of life in psoriatic arthritis - findings from a nationwide registry Reuma.pt
Sociodemographic factors and biologic therapy exposure impacting health-related quality of life in psoriatic arthritis - findings from a nationwide registry Reuma.pt Open
View article: POS0287 LONG TERM COMORBIDITY PATTERNS IN JUVENILE IDIOPATHIC ARTHRITIS
POS0287 LONG TERM COMORBIDITY PATTERNS IN JUVENILE IDIOPATHIC ARTHRITIS Open
View article: ABS0303 JUVENILE IDIOPATHIC ARTHRITIS (JIA) WITH CHRONIC ANTERIOR UVEITIS – LONG-TERM PROGRESSION AND CLASSIFICATION INSIGHTS
ABS0303 JUVENILE IDIOPATHIC ARTHRITIS (JIA) WITH CHRONIC ANTERIOR UVEITIS – LONG-TERM PROGRESSION AND CLASSIFICATION INSIGHTS Open
View article: MMTEB: Massive Multilingual Text Embedding Benchmark
MMTEB: Massive Multilingual Text Embedding Benchmark Open
Text embeddings are typically evaluated on a limited set of tasks, which are constrained by language, domain, and task diversity. To address these limitations and provide a more comprehensive evaluation, we introduce the Massive Multilingu…
View article: Neutrophile to lymphocyte and platelet to lymphocyte ratios predict clinical response to bDMARD in naïve spondylarthritis patients
Neutrophile to lymphocyte and platelet to lymphocyte ratios predict clinical response to bDMARD in naïve spondylarthritis patients Open
Objective: We aim to study association between neutrophile to lymphocyte (NLR) and platelet to lymphocyte (PLR) ratios and disease activity, and their value to predict bDMARD response. Methods: A set of spondylarthritis (SpA) patients unde…
View article: Polyarthritis due to metastatic calcinosis in a patient with new <i>WT1</i> gene mutation: resolution after renal transplantation
Polyarthritis due to metastatic calcinosis in a patient with new <i>WT1</i> gene mutation: resolution after renal transplantation Open
View article: Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomes
Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomes Open
View article: AB1246 SOCIOECONOMIC STATUS, WORK IMPAIRMENT, DISABILITY AND SEVERITY OF GOUT IN LATIN AMERICA (LAT)
AB1246 SOCIOECONOMIC STATUS, WORK IMPAIRMENT, DISABILITY AND SEVERITY OF GOUT IN LATIN AMERICA (LAT) Open
View article: Sex and body mass index impact on digit circumference for Leeds Dactylitis Index calculation
Sex and body mass index impact on digit circumference for Leeds Dactylitis Index calculation Open
OBJECTIVES: To estimate digit circumference and the impact of sex and body mass index (BMI) for the calculation of the Leeds Dactylitis Index (LDI) in psoriatic arthritis (PsA) patients with bilateral dactylitis. METHODS: Digit circumferen…
View article: Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long- term outcomes
Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long- term outcomes Open
Backgroud : Juvenile idiopathic arthritis (JIA) treatment is aimed at inducing remission to prevent joint destruction and disability. However, it is unclear what is the long-term impact on health-related outcomes of the timing of biologica…
View article: Neutrophile to Lymphocyte and Platelet to Lymphocyte Ratios Predict Clinical Response to Bdmard in Naïve Spondylarthritis Patients
Neutrophile to Lymphocyte and Platelet to Lymphocyte Ratios Predict Clinical Response to Bdmard in Naïve Spondylarthritis Patients Open
View article: Adult progeria: a new mutation in the WRN gene
Adult progeria: a new mutation in the WRN gene Open
Werner syndrome (WS), also known as adult progeria, is a rare autosomal recessive inherited progeroid syndrome characterised by multiple features consistent with accelerated ageing. This disease is associated with several rheumatic conditi…
View article: Risk Factors for Infection, Predictors of Severe Disease, and Antibody Response to COVID-19 in Patients With Inflammatory Rheumatic Diseases in Portugal—A Multicenter, Nationwide Study
Risk Factors for Infection, Predictors of Severe Disease, and Antibody Response to COVID-19 in Patients With Inflammatory Rheumatic Diseases in Portugal—A Multicenter, Nationwide Study Open
Objective To identify risk factors for SARS-CoV-2 infection and for severe/critical COVID-19, and to assess the humoral response after COVID-19 in these patients. Methods Nationwide study of adult patients with inflammatory RMDs prospectiv…
View article: Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance Open
View article: Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseases
Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseases Open
Objective To compare physical disability, mental health, fatigue and health-related quality of life (HRQoL) across juvenile idiopathic arthritis (JIA) categories in adulthood and between JIA and adult-onset rheumatic diseases. Methods Cros…
View article: Risk factors for infection, predictors of severe disease and antibody response to COVID-19 in patients with rheumatic diseases in Portugal – a multicentre, nationwide study
Risk factors for infection, predictors of severe disease and antibody response to COVID-19 in patients with rheumatic diseases in Portugal – a multicentre, nationwide study Open
In order to identify risk factors for SARS-CoV-2 infection as well as for severe/critical COVID-19 in rheumatic and musculoskeletal diseases (RMDs) patients, we conducted a multicentre observational nationwide study of adult patients prosp…
View article: PMS10 Real-World Characteristics of Ankylosing Spondylitis Patients WHO Started Treatment with Secukinumab: Nationwide Results from the Reuma.PT Registry
PMS10 Real-World Characteristics of Ankylosing Spondylitis Patients WHO Started Treatment with Secukinumab: Nationwide Results from the Reuma.PT Registry Open
View article: AB1145 PRESCRIPTION PATTERNS AND DISEASE ACTIVITY IN PORTUGUESE WOMEN OF CHILDBEARING AGE WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, ANKYLOSING SPONDYLITIS AND JUVENILE IDIOPATHIC ARTHRITIS
AB1145 PRESCRIPTION PATTERNS AND DISEASE ACTIVITY IN PORTUGUESE WOMEN OF CHILDBEARING AGE WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, ANKYLOSING SPONDYLITIS AND JUVENILE IDIOPATHIC ARTHRITIS Open
View article: Reuma.pt/vasculitis – the Portuguese vasculitis registry
Reuma.pt/vasculitis – the Portuguese vasculitis registry Open
View article: GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis
GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis Open
View article: AB0270 POSITIVE ACPA WITHOUT EVIDENCE OF ARTHRITIS – A RARITY?
AB0270 POSITIVE ACPA WITHOUT EVIDENCE OF ARTHRITIS – A RARITY? Open
View article: SAT0143 SAFETY AND EFFECTIVENESS OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS
SAT0143 SAFETY AND EFFECTIVENESS OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS Open
View article: SAT0368 GO-DACT: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLED PROOF-OF-CONCEPT TRIAL OF GOLIMUMAB PLUS METHOTREXATE (MTX) VERSUS MTX MONOTHERAPY, IN IMPROVING DACTYLITIS, IN MTX NAïVE PSORIATIC ARTHRITIS PATIENTS
SAT0368 GO-DACT: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLED PROOF-OF-CONCEPT TRIAL OF GOLIMUMAB PLUS METHOTREXATE (MTX) VERSUS MTX MONOTHERAPY, IN IMPROVING DACTYLITIS, IN MTX NAïVE PSORIATIC ARTHRITIS PATIENTS Open
View article: AB0533 Pattern of drug use in systemic lupus erythematosus in real world clinical practice
AB0533 Pattern of drug use in systemic lupus erythematosus in real world clinical practice Open
View article: OP0315 Reasons for discontinuation of biological agents in patients with juvenile idiopathic arthritis: data from the portuguese register, reuma.pt
OP0315 Reasons for discontinuation of biological agents in patients with juvenile idiopathic arthritis: data from the portuguese register, reuma.pt Open
View article: Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study Open
The long treatment duration of SC MTX highlights its excellent tolerability compared to oral MTX, especially concerning the frequent adverse gastrointestinal events of MTX. Furthermore, long MTX treatment duration provides the opportunity …
View article: Effectiveness and long-term retention of anti-tumour necrosis factor treatment in juvenile and adult patients with juvenile idiopathic arthritis: data from Reuma.pt
Effectiveness and long-term retention of anti-tumour necrosis factor treatment in juvenile and adult patients with juvenile idiopathic arthritis: data from Reuma.pt Open
Biologic therapies seem effective and safe in patients with JIA. In addition, the retention rates for the first biologic agent are high throughout 4 years.